3 new crown pneumonia potential "special effects medicine" who will be the real "black horse"?

At present, the new crown pneumonia is also spreading rapidly in the world, the emergence of its "special effects medicine" has become the world's people's expectations, more and more medical developers around the world have joined the new crown "special effects medicine" development ranks.
recently, Redsewe, once considered a "special-effects drug", does not appear to have a promising cure rate when used abroad, and another drug, lopinavir, has been shown to be ineffective.
therefore, the real "special effects drug" has not yet appeared, drug development is far from over.
recently, Japanese and French medical researchers have reported on the efficacy of nafamostat, hydroxychloroquine and Azithromycin for new coronary pneumonia, with hydroxychloroquine and Athromycin being used as drugs.
Figure I Nafamostat structural form of Nafamostat is a pancreatitis treatment drug that has been used for more than 30 years and has been shown to be effective against the MERS virus.
, therefore, the trial of a new type of coronavirus is also a matter of course, and this time it has been proven to be effective, and Japan has now included Nafamostat as a candidate for the new coronapneumonia treatment.
Hydroxychloroquine and its analogy of Hydroxychloroquine and its analogy have been shown to be effective in patients in China, and this time France has been linked to Azithromycin, which has been 100% effective with new coronary pneumonia, providing new evidence of its efficacy of the new coronapneumonia.
hydroxychloroquine is the main indications of malaria, which can be used for malaria prevention and treatment, as well as for the treatment of systemic and disc erythematosus and rheumatoid arthritis.
in recent years, the new use of old medicine research is quite a lot, hydroxychloroquine has also been found to have a better preventive effect on postoperative thromboembolism, this is used for the treatment of new coronary pneumonia, but also "old medicine new use" another model.
Azithromycin structural azithromycin is a 15-yuan cyclic ester antibiotic.
its main indications are mainly bacterial-related diseases, such as: acute pharyngitis caused by streptococcus, acute tonsillitis;
french medical workers found that Azithromycin combined hydroxychloroquine was 100 percent effective at the new crown pneumonia, a major new discovery. Another advantage of this combination drug regimen is that it can be used as a treatment for the new coronavirus and prevents bacterial cross-infection,
medical staff said.
France has considered promoting the joint drug programme, and larger clinical studies have been launched.
we can see that the world is increasing investment in the research and development of new crown drugs, Redseywei in recent days has also been the United States FDA orphan drug certification, chloroquine, hydroxychloroquine has also been included in the United States, Japan's new crown pneumonia drug system.
As more and more pharmaceutical workers join the research and development of the new "special effects medicine" of pneumonia, I believe there will be more excellent new coronary pneumonia treatment, let's wait and see.
References: 1. 2. .
original title: Research and development , in the short term, there are 3 new crown pneumonia potential "special effects medicine", who will be the real "black horse"?